Comply with mandates and strengthen your strategy with our testing options. The forthcoming OSHA ETS requires employers with 100+ employees to mandate that their workers be vaccinated or undergo weekly testing. These requirements for ETS compliance will tremendously increase the workload to HR.
Achieve Health Management has partnered with CrisisGo Safety iPass 3.0 to meet and exceed the OSHA ETS in most states.
Identify and Update Vaccinated and Unvaccinated Employee Information
Determine how employees are to report the results of the testing.
Establish a record keeping strategy that supports the compliance.
CrisisGo offers the utmost streamlined and secure way for schools and businesses manage the full scope of COVID-19 safety needs.
CrisisGo Safety iPass conforms to CDC and all COVID-19 protocols including OSHA ETS, helping you comply with local COVID-19 guidelines and laws. CrisisGo Safety iPass allows you to combine symptoms, vaccination status and test results to determine the status of a person’s ability to enter a facility.
Safety iPass is an easy-to-use, intelligent, real-time digital health management solution that assigns a badge status for entry, based on the results of Health Surveys (testing opt-in and CDC screening surveys), Vaccination Status & Test Results (with expiration date management), and any symptoms screening information. Status verification of those entering your facility or specific area within the facility can be managed by scanning staff ID badges, QR codes in the CrisisGo app, QR code printed badges, or reviewing the status via web portal.
Used by over 500,000 users and available in several languages.
Doesn't require any staff to download an application
CrisisGo Safety iPass solution was released based upon CDC, OSHA, and FEMA guidelines.
Achieve Health Management provides comprehensive solutions for the range of COVID-19 testing needs
This project is supported by the National Testing Action Program (NTAP) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $10B with 100 percent funded by the Centers of Disease Control and Prevention (CDC) as well as the HHS Coordination Hubs. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by the CDC/HHS, or the U.S. Government. For more information please visit DSHS.Texas.gov
This test is only authorized for use in CLIA-certified laboratories that meet requirements for high complexity tests. This test has not been FDA cleared or approved. This test has been authorized by FDA under and EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner (Section IV(BB)).
2211 Encinitas Boulevard, Suite, 200
Encinitas, CA 92024
Copyright © 2021 Achieve Health Management
